We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characteristics of Patients With Thymoma in Chulalongkorn Hospital

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01123590
First Posted: May 14, 2010
Last Update Posted: November 23, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Chulalongkorn University
  Purpose
The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.

Condition
Thymoma Staging Clinical Presentations Associated Disorders Laboratory Findings

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Characteristics of Patients With Thymoma Undergone Thymectomy in Chulalongkorn Hospital Between 2003-2007

Resource links provided by NLM:


Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:
  • Thymoma staging and clinical manifestations [ Time Frame: 5 years ]

Secondary Outcome Measures:
  • Associated diseases and laboratory findings Immunological data [ Time Frame: 4 months ]

Biospecimen Retention:   Samples Without DNA
PBMC

Enrollment: 50
Study Start Date: November 2009
Study Completion Date: October 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Thymoma
Patients with thymoma
Control
Normal controls

Detailed Description:
To study characteristics of patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007 in terms of clinical manifestations, associated diseases, and laboratory findings.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007
Criteria

Inclusion Criteria:

  • Patients with histocytological proved thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01123590


Locations
Thailand
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
Investigators
Principal Investigator: Jettanong Klaewsongkram, MD Chulalongkorn University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jettanong Klaewsongkram, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01123590     History of Changes
Other Study ID Numbers: Chula-ARC 003/09
First Submitted: May 12, 2010
First Posted: May 14, 2010
Last Update Posted: November 23, 2010
Last Verified: November 2010

Keywords provided by Chulalongkorn University:
Thymoma
Autoimmune diseases
Immunodeficiency

Additional relevant MeSH terms:
Thymoma
Thymus Neoplasms
Neoplasms, Complex and Mixed
Neoplasms by Histologic Type
Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lymphatic Diseases